Return to homepagePandemic Pact

Cardiac Imaging in SARS Coronavirus disease-19 (CISCO-19)

Grant number: COV/GLA/20/05

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $59,445.6

  • Funder

    CSO Scotland

  • Principal Investigator

    Prof. Colin Berry

  • Research Location

    United Kingdom

  • Lead Research Institution

    University of Glasgow

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Drug usersSex workers

  • Occupations of Interest

    Unspecified

Abstract

One-in-four patients with COVID-19 pneumonia develop life-threatening heart problems. Our research idea is that virus can directly infect the heart. We will study which patients are at-risk of heart injury and why only some patients suffer heart problems. MRI scans help doctors identify heart damage and its causes and explain blood tests such as those for troponin (protein released into the bloodstream during a heartattack). During a 3-month period, hospitalised patients with COVID-19 will have blood tests and then a heart-lung scan after discharge. We will clarify links between the heart/lungs & risk factors to support development of preventive therapies.